Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment

Grant

Awarded By

Total Award Amount

  • 10618.00

    • Direct Costs

  • 7150.00

    • Sponsor Award Id

  • 0000000660

    • Contributor

  • Yedeh Ying M.D.   Principal Investigator